https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
9% (95% confidence interval 6.1% -14.6%, total pooled sample size 1508 eyes) with high heterogeneity between studies [I2 = 86.48% (95% confidence interval 80.98 - 90.39), P 0.0001]. When considering KC progression after CXL in children, with an increase in Kmax, Kmean, or Ksteep ≥ 1.0 diopter, the progression risk was roughly 10%. We encourage clear quantitative reporting of KC progression in future studies evaluating CXL efficacy in pediatric populations. When considering KC progression after CXL in children, with a
Like
Comment
Share
